Articles Archives - Page 83 of 129

MondayAug 20, 2018 1:36 pm

Rising Need for Data Analytics Bodes Well for Consorteum Holdings, Inc. (CSRH)

Big data and business analysis revenues expected to reach $166 billion this year, $260 billion by 2022 Consorteum Holdings’ lead product, the Universal Mobile Interface™, provides adaptable Big Data capabilities to variety of industries Company’s first app targets sports betting interests of world’s cricket fans The surging interest in data analytics tools bodes well for analytical software development company Consorteum Holdings, Inc. (OTC: CSRH), which aims to distribute its central product, the Universal Mobile Interface (UMI), to businesses intent on integrating data streams to generate revenue via mobile platforms. Consorteum Holdings is focused on the delivery of digital content to…

MondayAug 20, 2018 1:09 pm

Cannabis Strategic Ventures, Inc. (NUGS) Expands Footprint in Billion-Dollar Asian Nutraceuticals Market

CBD market projected to grow to $2.1 billion by 2020 Large Asian-American market receptive to traditional Chinese medicine and nutraceuticals Cannabis Strategic Ventures combines brand experience with niche knowledge Cannabis Strategic Ventures, Inc. (OTC: NUGS) is out to take a slice of the billion-dollar Asian Nutraceutical pie. The company recently cut a deal to acquire the Fitamins CBD brand (http://ibn.fm/JzrDg). Under the terms of the agreement, Fitamins will be distributing its vitamin and hemp-derived CBD formulations through a network of more than 600 wholesalers that serve the Asian-American market. Guided by a team that has developed two successful ventures, Cannabis Strategic…

MondayAug 20, 2018 11:59 am

ChineseInvestors.com, Inc. (CIIX) Eyes CBD Spin Off as ChineseHempOil.com Subsidiary Hosts Seminar for Chinese Wellness Center in Los Angeles

In MoneyTV interview, Warren Wang, CEO of CIIX, says that the plan is to spin off cannabis line next year, adding that the goal is for CIIX shares to grow from $0.50 to $5.00 in three to five years CIIX’s CBD division to include CBD Biotechnology Co. Ltd., Hemp Logic, Inc. and ChineseHempOil.com, Inc. After the spinoff of CBD assets, CIIX will return to its roots in consulting, brand building and education for the Chinese-speaking community in the U.S. and international markets ChineseInvestors.com, Inc. (OTCQB: CIIX) subsidiary ChineseHempOil.com, Inc. is growing the strategic retail placement of its CBD-related products and…

MondayAug 20, 2018 11:31 am

Development Continues on QMC Quantum Minerals Corp.’s (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Mine Property as Lithium Demand Climbs

The Irgon Lithium Mine Property is a mineral-rich spodumene-bearing pegmatite dike with significant historical data that point to additional as-of-yet untapped potential The property is uniquely positioned to be brought into production much faster than expected for a project of this size due to work previously done Lithium demand is projected to continue to rise thanks to electrification of both civilian and commercial transport, as well as the expansion of energy storage technology As global lithium demand continues to rise with the electrification of the global transportation fleet, QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) finds itself…

FridayAug 17, 2018 1:41 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery

Smoking-related deaths have reached six million a year worldwide Lexaria’s patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking’s hazards Second round of testing continues to indicate that patented DehydraTECH™ platform provides rapid delivery with high bioavailability As world drug industry regulations undergo revolutionary change and increasingly healthy populations find themselves challenged to meet the cares of old age, Canadian biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is forging a path that establishes it as a pioneer in the field of drug delivery platforms. Lexaria’s mission is to ensure…

FridayAug 17, 2018 1:15 pm

Preparation, Opportunity Strengthen First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) Outlook as Potential Supplier of In-Demand Metal

Tech-industry demand for cobalt predicted to drive doubling of need for battery element during next decade First Cobalt exploring quick-to-market potential of Idaho project while assessing fire-up capacity of continent’s only permitted cobalt refinery Company also has 50 past-producing mines in Canada’s famed Cobalt Camp Cobalt’s rising star in the metal commodities market and the potential fast-track-to-production resources of First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) appear to be a rock solid marriage of preparation and opportunity within the exploration industry. Cobalt’s clout derives from its current position as a limited supply element vital to the low-heat, high-stability…

FridayAug 17, 2018 12:03 pm

NUGL Inc. (NUGL) Cannabis Brand Locator, Profile App Set to Sweep North America

Comprehensive, flexible web app technology means superior service that meets the needs of expanding cannabis community and industry Powerful web app based engine offers unique search functionality, profile building and networking capabilities for cannabis cultivators, brands, dispensaries and all associated service-related industries U.S. legal cannabis market projected to reach more than $23 billion in consumer spending by 2022 NUGL app gives consumers easy-to-locate info on all things cannabis, with unbiased reviews connecting users to their favorite brands, locations Serving international markets with no geographic limitations thanks to innovative, first-to-market technology NUGL Inc. (OTC: NUGL), the cannabis industry’s new standard of…

FridayAug 17, 2018 11:33 am

CytoDyn Inc. (CYDY) is “One to Watch”

PRO 140 is a leading monoclonal antibody/viral-entry inhibitor therapy under development for two different Human Immunodeficiency Virus (HIV) indications and is also being pursued for multiple opportunities in other immunologic indications such as autoimmune disease, chronic inflammation, certain cancers, and transplant rejection During 2017, 1.8 million people became newly infected with HIV, bringing the global total to 36.9 million people living with HIV (World Health Organization) Market potential for PRO 140 used as an anti-viral agent in combination with HAART is $1.2 billion; as a monotherapy maintenance/single-drug therapy the market is estimated at $3.8 billion CytoDyn Inc. (OTCQB: CYDY) is…

ThursdayAug 16, 2018 1:44 pm

PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Targets Treatment Option for Anxiety Disorders

Anxiety is implicated in several chronic physical illnesses including heart disease, respiratory disorders and gastrointestinal conditions Scientific evidence in several studies shows that CBD exhibits anti-inflammatory and anti-anxiety properties Newly created medicinal cannabis division will focus on development of cannabinoids as preventative treatment for anxiety disorders Use of PreveCeutical’s proprietary Sol-gel nasal delivery platform for cannabinoid therapy promises ease of use, sustained release, better efficacy Preventative medicine industry represents a $3.8 trillion market Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is tackling a topic that many people hesitate to bring up – anxiety disorders, including…

Site Search

Company Search

Category: Articles